Subramaniyam et al. discovered that treatment with granulocyte-macrophage colony-stimulating factor (GM-CSF) could mobilize EPCs, repair endothelial dysfunction, and restore injured vascular tissue in patients with peripheral arterial disease (PAD) [97]. Here, CSF2 is linked to peripheral arterial disease.